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Abstract
Background: Diagnosis of childhood tuberculosis (TB) is difficult in high TB burden settings. Interferon-gamma-induced
protein 10 (IP10) has been suggested as a marker of TB infection and disease, but its ability to differentiate the two
conditions remains uncertain.
Objectives: To describe Interferon-gamma (INFc) and IP10 expression in children with TB infection and disease and controls
to assess their potential to differentiate latent and active TB.
Methods: This was a cross sectional study of 322 1–15 years old children with symptoms of TB (28 confirmed, 136 probable
and 131 unlikely TB), 335 children in contact with adults with pulmonary TB and 156 community controls in Southern
Ethiopia. The Tuberculin Skin Test (TST) and Quantiferon-In-Tube (QFT-IT) were performed. INFc and IP10 were measured in
plasma supernatants.
Results and Interpretation: Children with confirmed and probable TB and contacts were more likely to have TST+ (78.6%,
59.3% and 54.1%, respectively) than children with unlikely TB (28.7%) and controls (12.8%) (p,0.001). Children with
confirmed TB (59.3%) and contacts (44.7%) were more likely to have INFc+ than children with probable (37.6%) or unlikely TB
(28.1%) and controls (13.1%) (p,0.001). IP10 concentrations were higher in INFc+ children independently of TST (p,0.001).
There was no difference between IP10 concentrations of children with confirmed TB and contacts (p=0.8) and children with
and without HIV (p.0.1). INFc and IP10 can identify children with TB infection and disease, but cannot differentiate
between the two conditions. HIV status did not affect the expression of IP10.
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Introduction
One of the most significant barriers for the appropriate
management of Tuberculosis (TB) is the lack of suitable diagnostic
tests.This problem is especially criticalinsettingswherefacilities are
limited and other infections with overlapping clinical presentation
are highly prevalent. Childhood TB presentation differs from adult
TB as children experience more extra-pulmonary TB (EPTB) and
lung involvement is frequently disseminated and without cavita-
tions. Young children are unable to expectorate sputum and the
specimens collected, such as gastric aspirates, are often paucibacil-
lary and sometimes contain test inhibitors. Most diagnostics for TB
thus perform poorly in children [1,2] and new tests or markers to
diagnose TB in children are needed.
Interferon-gamma (INFc) release assays (IGRAs) were developed
in the last decade and are reported to have comparable sensitivity
and higher specificity than the Tuberculin Skin Test (TST) to
identify latent TB infections (LTBI). Their performance however is
less reliable in young children and in patients co-infected with the
Human Immunodeficiency Virus (HIV) [3,4,5]. These assays are
frequently used by clinicians to support a diagnosis of symptomatic
TB [3,6,7], even though they cannot distinguish between LTBI and
symptomatic disease. IGRAS are also increasingly used in high TB
incidence settings, despite the limited information of their
performance in these locations [8,9,10].
INFc-induced protein 10 (IP10, also known as Chemokine (C-
X-C motif) ligand 10 or CXCL10) is another biomarker recently
reported to identify LTBI, which, when combined with IGRAS is
said to increase the sensitivity of the assays [10]. IP10 expression is
putatively less affected by HIV [11] and young age [12,13] and it
is said to have potential to differentiate between LTBI and
symptomatic infections [12,14].
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e23733We have thus conducted a study in Southern Ethiopia to
describe INFc and IP10 concentrations of children presenting with
symptoms compatible with TB, asymptomatic children in con-
tact with adults with smear-positive pulmonary TB (PTB) and
asymptomatic community controls to explore whether INFc or
IP10 can distinguish between symptomatic and asymptomatic
infections in a high TB burden setting and assess whether these
markers could be used to support the diagnosis of children with
symptoms of TB.
Materials and Methods
This was a cross sectional study of 1 to 15 year old children with
symptoms suggestive of TB, children in contact with adults with
smear-positive PTB and community controls without known
contact with TB. The study was based in Awassa, in the Southern
Region of Ethiopia, which has a population of over 15 million.
Children with symptoms of TB (called symptomatics) were
enrolled consecutively at three health service providers (Awassa
Health Centre, Bushullo Major Health Centre and University of
Hawassa referral hospital). These included consecutive children
with cough or fever for more than 2 weeks, night sweats, anorexia,
weight loss, failure to thrive or non-specific symptoms in the
presence of a history of contact with an adult with PTB. Children
were invited to participate at the time of presentation to the clinic.
All children underwent a clinical examination, chest X-rays, TST,
three sputum or gastric lavage examinations and fine needle
aspiration if enlarged lymph nodes were detected. All specimens
were examined using light smear microscopy and culture on
Lowenstein Jensen media and children were classified as having
confirmed (positive smear microscopy or culture), probable (negative
smear microscopy and culture, clinical and radiological findings
consistent with TB, no improvement after a full course of antibiotics
and the clinician initiating anti-TB treatment) or unlikely TB
(children with alternative diagnosis or clinical improvement after
a course of broad spectrum antibiotics).
In addition, contact children 1–15 year old residing with adults
with smear-positive PTB (called contacts) were enrolled by
identifying adults attending the same study centres with a history
of cough for more than 2 weeks duration who had sputum smear-
positive PTB. Once a smear-positive adult had been identified,
study investigators inquired whether they had children at home
and visited the households if the family resided within a 20 km
radius from Awassa. All children living under a single roof who
shared meal times with the adult were invited to participate after
obtaining informed parental consent, unless they had previously
received treatment for TB. All children who shared meals at home
with the index cases were included, regardless of the duration of
contact.
Community controls were defined as children residing in the
community who did not have a known contact with adults with
PTB. Controls were selected from Awassa and surrounding kebeles,
which are the smallest administrative units of Ethiopia and
comprise at least five hundred families or 3,500 to 5,000
inhabitants. A list of all villages and kebeles located within a
20 Km radius from Awassa was constructed. Controls were
enrolled from villages adjacent to the villages where contacts
resided. We enrolled more controls from rural villages than from
urban areas as the risk of TB transmission from casual contact
could be higher among urban residents. Households within a
village were selected by spinning a pen in a street somewhere
between the centre and the edge of the village and children were
enrolled after obtaining informed parental consent. Households
were excluded if the parent indicated the family had been in
contact with an adult with cough for more than 2 weeks duration
in the previous 2 years or if a family member had received
treatment for TB. All children were applied a TST using 2 units of
Purified Protein Derivate (PPD, RT 23, Statens Serum Institute,
Copenhagen, Denmark) using the Mantoux method and indura-
tions were measured using the palpation method 48 to 72 hours
later. TST results were graded as negative (,5 mm), intermediate
($5 and ,10 mm) and positive ($10 mm). Any child with signs
and symptoms suggestive of TB was investigated for disease
activity and treated. Contact children ,6 years old were offered
INH prophylaxis for 6 months independently of their TST result,
following Ethiopian TB Control Programme guidelines.
INFc and IP10 concentrations were assayed using commercially
available Enzyme Linked Immunoassay (ELISA) kits. INFc was
measured using the QuantiFERON-TB Gold In-Tube (QFT-IT)
test (Cellestis, Victoria, Australia). Blood samples for QFT-IT were
collected in 3 tubes, one containing the Mycobacterium tuberculosis
ESAT-6, CFP10 and TB7-7 antigens; one with non-specific
mytogen (phytohemoagglutinin) to serve as positive control and
one blank tube (nil) to serve as negative control. The three tubes
were incubated at 37u for 16–24 hours. Supernatant plasma was
harvested after centrifugation to separate the blood cells and
stored at 270uC. INFc was measured using the manufacturer’s
ELISA in a Bio-Rad Plate reader (Model n 550) and read at
450 nm. IGRAs were classified as positive, negative or indetermi-
nate using the manufacturer’s software. IP10 concentrations were
measured in the same supernatant using a Human IP10 ELISA
Construction Kit (Antigenix America Inc, New York, NY). HIV
infections were established using two blood-based ELISA methods.
Means and standard deviations (SD) or medians and inter-
quartile ranges (IQR) were used to describe continuous variables.
Parametric tests and non parametric tests were used to compare
means and medians. The proportion of children in each study
category with positive/negative tests compared using Chi-Square
and Fisher’s exact tests (if expected values were less than,5)
and the agreement between TST and INFc was described using
Kappa statistics. IP10 concentrations were described using
boxplots stratified by TST and INFc concordance. The sample
size calculations took into account the feasibility to visit about 200
households (of index cases) within the available time and resources
and that each household had an average of two children ,5 years
old and it was expected that 200 children with signs and sypmtoms
of TB would attend the health services. It was expected that 50%
of the participants would be TST positive and 70% and 30%, of
TST-positive children would be INF-c positive and negative,
respectively. It was also assumed that 30% and 70% of TST-
negative children would be INF-c positive and negative, respec-
tively. This sample size would allow estimating the proportion
of children with positive and negative INF-c results by study
group with a precision of 67%. Sample size calculation for the
comparison of quantitative data (i.e. differences in IP-10 concen-
trations by study group) would have required prior information
of the dispersion of IP-10 concentrations to estimate standard
deviations or medians. As this information was not available, this
study should be considered ‘‘exploratory’’, as it might not have
enough power for the differences reported. The ability of IP10 to
discriminate between children with and without TB infection or
disease was evaluated using Receiver Operating Characteristic
(ROC) curves using Prism 5 software (GraphPad PRISM, version
5). ROC curves were constructed with children with confirmed TB
and controls and contact children with TST+/INFc+ and controls.
Only controls with TST-/INFc- results were included in the ROC
analysis to select children unlikely to have TB infection. The area
under the curve (AUC) for both confirmed and contact children were
INFc or IP10 to Differentiate Active and Latent TB
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two conditions. Statistical tests were considered significant if p
values were ,0.05.
The study protocol was approved by the Health Bureau of the
Southern Region and the Research Ethics Committees of the
Liverpool School of Tropical Medicine, Hawassa University and
the Sciences and Technology Commission of Ethiopia. The study
protocol was registered in the clinicatrials.gov clinical trials register
(registration number NCT00456469)
Results
Eight hundred thirteen, 322 symptomatic, 335 contact and 156
control children were enrolled. The flow chart of the three groups is
described in Figure 1. Twenty eight (8.7%) of 322 symptomatic
children had confirmed, 136 (42.2%) probable and 131 (40.7%) unlikely
TB and 27 were excluded because a definitive diagnosis was not
reached or the child left the hospital before completing the
investigations. The 335 contact children were recruited from 125
adult index cases who had ‘‘scanty’’ (18, 5.5%), ‘‘+’’ (188, 57%),
‘‘++’’ (109, 33%) or ‘‘+++’’ (15, 4.5%) smear microscopy grades in
their sputum smear examination. In five contacts the smear result of
the adult was not recorded. The median contact duration was
10 hours per week (range of 1 to 41 hours). The characteristics of
the participants are shown in Table 1. Children with probable TB
were more likely to be male (67.6%), while children in the other
groups had similar proportions of males and females. Children had
similar median age with symptomatic and control children having
a median age of 6 years and contacts having a median of 8 years.
Although the proportion of children reporting to have received
BCG was similar across the groups, BCG scars were found less
frequently in children with confirmed and probable TB (p,0.001).
HIV was positive in none of the children with confirmed TB, 14
(10.9%) children with probable and 8 (6.5%) unlikely TB cases, 27
(8.2%) contacts and 3 (1.9%) controls (p=0.005). The number of
residents per household was higher among children with symptoms
of TB than among contacts and controls (means 8, 7.1 and 6.4
persons, respectively, p=0.003). A significantly high proportion of
children had lost one or both parents, with symptomatic and contact
children being more likely to have lost a parent than controls
(p=0.01).
TST and INFc results areshown in table 2. Children with confirmed
and probable TB and contacts were more likely to have positive TST
(TST+) (78.6%, 59.3% and 54.1%, respectively) than children with
unlikely TB (28.7%) and controls (12.8%) (p,0.001). A high proportion
of children had indeterminate INFc tests, with children with probable
and unlikely TB having a higher proportion of indeterminates than
children with confirmed TB, contacts and controls. This problem was
mostly due to failure of the positive control tube and was not
associated with HIV infection (26/52 (50%) in HIV positive,
compared to 256/641 (40%) in HIV-negative children, p=0.2).
Children with confirmed TB (59.3%) and contacts (44.7%) were
also more likely to have positive INFc (INFc+) than children with
probable (37.6%) or unlikely TB (28.1%) and controls (13.1%)
(p,0.001). Twenty two (78.6%) children with confirmed,7 3
(53.7%) with probable and 68 (52%) with unlikely TB, 209 (62.4%)
contacts and 114 (73.1%) controls had paired TST and IFNc results
after exclusion of intermediate TST and indeterminate INFc tests.
Concordance between INFc and TST varied across the groups.
Children with confirmed and probable TB and contacts were more
likely to have concordant positive TST and INFc (15 (68.2%) of
22, 38 (52.1%) of 73 and 87 (41.6%) of 209, respectively), while
children with unlikely TB and controls were more likely to have
concordant negative TST and INFc (29 (42.6%) of 68 and 86
(75.4%) of 114, respectively). Discordant TST+/INFc2 results
were more frequent among children with probable TB (20.5%) and
contacts (18.7%) and discordant TST2/INFc+ results were more
frequent among children with unlikely TB (22.1%) and controls
(11.5%). Agreement between TST and IFNc tests varied from
81% (k=0.49) in children with confirmed TB, 73% (k=0.40) in
probable TB and 66% (k=0.23) in unlikely TB, 70% (k=0.39) in
contacts and 81% (k=0.24) in controls.
Figure 1. Flow chart of study participants.
doi:10.1371/journal.pone.0023733.g001
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concentrations were much higher than non-stimulated concentra-
tions in all groups (p,0.001). Non-stimulated concentrations were
highest in children with confirmed TB and lowest in controls (medians
1606 and 386 pg/ml). Stimulated concentrations were higher in
children with confirmed TB and contacts (7812 and 5616 pg/ml,
respectively) than in children with probable and unlikely TB (3680
and 2532 pg/ml, respectively, Kruskal-Wallis, p=0.02). The
difference of stimulated minus non-stimulated concentrations
are shown in Table 3 by TST and INFc results and study group.
Among patients with positive TST, symptomatic and contact
children had higher IP10 concentrations than controls (p=0.03
and p,0.001, respectively). Among children with negative
TST, children with confirmed TB and contacts had higher IP10
concentrations than controls (p=0.02 and p=0.001, respectively.
There was no difference in the IP10 concentrations across study
groups among children with INFc2 results, while contact children
with INFc+ results had the highest IP10 concentrations, followed
by symptomatic and control children. Median (IQR) IP10 concentra-
tions (stimulated minus non-stimulated) are shown in Figure 3 by
TST and INFc concordance. Children with concordant TST+/
INFc+ had higher IP10 concentrations than children with TST2/
INFc2 results in all study groups. Children with confirmed TB had
high IP10 concentrations independently of the TST or INFc result
including two of the three children who had TST2/INFc2
results. In contrast, most controls had low IP10 concentrations with
the exception of children with TST+/INFc+ results, who had high
IP10 concentrations (p=0.04). Children with HIV had similar
Table 1. Characteristics of the study children.
Variables Symptomatic cases N=295
Confirmed TB
N=28
Probable TB
N=136
Unlikely TB
N=131
Contacts
N=335
Controls
N=156 p
Male/Female (% Male) 13/15 (46.4) 92/44 (67.6) 67/64 (51.1) 168/166 (50.3) 79/77 (50.6)
Median age (years) 8 5 7 8 6 ,0.001
Range 1–15 1–15 1–15 1–15 1–15
Received BCG 14 (63.6) 69 (63.3) 82 (70.7) 249 (74.3) 120 (76.9) 0.01
BCG scar present (%) 7 (25) 35 (25.7) 51 (38.9) 174 (51.9) 93 (59.6) ,0.001
Mean (SD) BCG scar (mm) 7.4 (3.2) 5.3 (1.8) 5.5 (2.1) 4.7 (2.4) 5.4 (2.5) ,0.001
Range 4–13 2–9 2–10 1–13 2–13
HIV status, Pos/tested (%Pos) 0/27 (0) 14/114 (10.9) 8/116 (6.5) 27/231 (8.2) 3/153 (1.9) 0.005
Mean (SD) residents/household 8.3 (7.5) 8.9 (8.3) 7.2 (6.3) 7.1 (2.6) 6.4 (2.4) 0.002
Illiterate Father, N (%) 17 (70.8) 63 (55.8) 55 (48.7) 112 (38.6) 87 (60.4) ,0.001
Mother, N (%) 21 (84) 97 (77.6) 87 (68.5) 170 (52.3) 123 (78.8) ,0.001
Alive Father, N (%) 24 (85.7) 113 (83.1) 113 (86.3) 293 (88.3) 144 (92.3) 0.2
Mother, N (%) 25 (89.3) 124 (92.5) 128 (98.5) 325 (97.6) 156 (100) ,0.001
Both parents, N (%) 23 (82.1) 109 (81.3) 112 (80) 293 (88) 144 (92.3) 0.01
doi:10.1371/journal.pone.0023733.t001
Table 2. TST and INFc results and concordance among the tests by study group.
Variables Symptomatic cases N=295
Confirmed TB N=28 (%) Probable TB N=136 (%) Unlikely TB N=131 (%) Contacts N=335 (%) Controls N=156 (%)
TST
Positive 22 (78.6) 80 (59.3) 37 (28.7) 172 (54.1) 20 (12.8)
Intermediate 0 10 (7.4) 9 (7) 48 (15.1) 15 (9.6)
Negative 6 (21.4) 45 (33.3) 83 (64.3) 98 (30.8) 121 (77.6)
INFc
Positive 16 (59.3) 47 (37.6) 34 (28.1) 139 (44.7) 20 (13.1)
Indeterminate 5 (18.5) 47 (37.6) 44 (36.4) 52 (16.7) 25 (16.3)
Negative 6 (22.2) 31 (24.8) 43 (35.5) 120 (38.6) 108 (70.6)
TST/INFc concordance
TST+/INFc+ 15 (68.2) 38 (52.1) 14 (20.6) 87 (41.6) 6 (5.3)
TST+/INFc2 3 (13.6) 15 (20.5) 10 (14.7) 39 (18.7) 10 (8.8)
TST2/INFc+ 1 (4.5) 5 (6.8) 15 (22.1) 24 (11.5) 12 (10.5)
TST2/INFc2 3 (13.6) 15 (20.5) 29 (42.6) 59 (28.2) 86 (75.4)
doi:10.1371/journal.pone.0023733.t002
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groups (p.0.1) as shown in Figure 4.
IP10 concentrations of children with confirmed TB (N=22,
median IP10 7774 pg/ml) and contacts with TST+ and/or INFc+
(N=148, median IP10 12490 pg/ml) where compared against
controls with TST2 and INFc2 (N=86, median IP10 704 pg/ml)
to construct the ROC curves, as shown in Figure 5. The ROC
curves for both confirmed and contact children had the same shape,
with cut-off points for best performance being 3128 pg/ml
(sensitivity 81.8%, 95%CI=59.7–94.8, specificity 96.5% 95%CI
90.1–99.3 and area under the curve (AUC) of 0.87%, 95%CI
0.75–0.99) for confirmed TB and 3022 pg/ml (sensitivity 77%,
95%CI 69.4–83.5%, specificity 96.5%, 95%CI 90.14–99.3%, and
an AUC of 0.87, 95%CI 0.82–0.92) for contacts.
Discussion
Despite significant research efforts and technological break-
throughs to develop new diagnostics for TB [15], current
diagnostic tests have lower sensitivity in children than in adults
[1,2]. New diagnostics are needed to identify children with TB and
to differentiate between latent and active TB in high incidence
settings with limited resources.
Despite a large body of evidence of the performance
characteristics of IGRAs for the diagnosis of LTBI and the
identification of individuals infected during TB outbreaks in low
TB incidence settings [6,16,17,18,19], there is a small number of
studies assessing the IGRAS performance and their utility in high
incidence countries [20,21,22]. The data presented here therefore
represents a rare opportunity to compare TST, INFc and IP10 in
children with different degrees of exposure to infection and
certainty of diagnosis residing in a high TB burden setting.
An important difference to reports from industrialized countries
was the high proportion of QFT-IT tests with indeterminate
results. Other studies from Africa have reported high rates of
indeterminate results [23], and the reason for this high frequency
remains unexplained. Our team has conducted similar studies in
Nigeria [24], Nepal [8] and Yemen, took care to re-stock tests
frequently and used high altitude control tubes provided by the
manufacturer. Most indeterminate results however were due to
failure of the positive control and further studies are needed to
explore whether this was due to a loss of test integrity or an
unidentified background morbidity such as parasitic, bacterial or
viral infections [25]. The interpretation of the data is also
hampered by the lack of reference standards for LTBI. The data
however confirms that INFc, as TST, are more likely to be
Figure 2. IP10 (pg/ml) concentrations in stimulated (Ag) and non-stimulated (Nil) samples by study group. Box plots describe medians,
interquantile values and range. Asterisks depict outliers.
doi:10.1371/journal.pone.0023733.g002
Table 3. Medians and interquantile ranges of IP10 concentrations (stimulated minus non-stimulated, in pg/ml) according to the
TST and INFc results by study group.
TST INFc
Positive Intermediate Negative Positive Indeterminate Negative
TB confirmed 5116 (2092–9624) - 6788 (1672–11344) 8848 (4296–11414) 1672 (56–2092) 4560 (8–7496)
TB probable 2592 (64–8272) 768 (0–7424) 512 (84–3348) 7254 (3360–10548) 84 (0–604) 1288 (140–4548)
TB unlikely 2404 (326–8868) 2903 (692–8688) 674 (54–2558) 7594 (3328–12028) 548 (0–2208) 674 (120–1372)
Contacts 9304 (708–14536) 6078 (476–17632) 1486 (308–5544) 13800 (11128–17728) 348 (20–1932) 770 (196–3224)
Controls 528 (72–1392) 1124 (40–2320) 704 (116–1932) 1784 (364–2562) 180 (0–1184) 684 (144–1792)
doi:10.1371/journal.pone.0023733.t003
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Neither INFc nor TST differentiate between active and latent
infections and thus their diagnostic value is restricted to the
confirmation of a history of infection [3,19,26]. Given that a
number of children had discrepant INFc/TST results, cost and
logistic constrains aside, the use of both TST and INFc would
identify a higher number of children with evidence of infection
than a single test alone.
This study also describes IP10 concentrations of children at
different risk of infection, and how these concentrations vary with
TST, INFc and HIV. IP10 is a cytokine expressed in response to
IFNc stimulation by cell types involved in delayed-type
hypersensitivity [27], including lymphocytes, monocytes, endo-
thelial cells and fibroblasts and is a chemo-attractant to
monocytes and activated Th1 lymphocytes [28], promoting
selective enhancement of Th1 responses and increasing IFN-c
gene expression [29]. Recent studies have reported that IP10
expression is enhanced in individuals with active TB [30,31] and
latent infection [12,13,32] and that combined with INFc could
increase the sensitivity of the IGRAS [9,12]. Although some
reports have suggested that this marker could differentiate
between active and latent infection [14,33], not all studies have
replicated these observations [10,14].
IP-10 concentrations were higher among children with confirmed
TB and contacts, with the highest concentrations observed in contact
children, which is in agreement with recently recent reports from
low incidence settings [12,14]. IP10 concentrations were generally
higher among children with INFc+ results and there was no
difference in the median concentrations of children with and
without HIV infection. This latter characteristic could have
practical applications, increasing the sensitivity of INFc based tests
in areas of high HIV prevalence.
Figure 3. IP10 concentrations (stimulated minus non-stimulated) by TST and INFc results and study group. Box plots describe medians,
interquantile values and range. Asterisks depict outliers.
doi:10.1371/journal.pone.0023733.g003
Figure 4. IP10 concentrations (stimulated minus non-stimulated) by HIV status and study group. Box plots describe medians,
interquantile values and range. Asterisks depict outliers.
doi:10.1371/journal.pone.0023733.g004
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in children with confirmed TB, resulting in a smaller difference
between stimulated and non-stimulated concentrations. Although
non-specific IP10 increases have been described in acute and
chronic diseases other than TB [34,35,36,37], these findings
suggest that IP10 expression may vary during the course of disease
progression, maybe with higher expression during the primary
stages of granuloma formation, which involves the recruitment of
monocytes and Th1 gammadelta T-cells [38] and lower expression
in the presence of progressive unchecked infections, in the
presence of immunosuppression, as described for INFc.
The ROC curve analysis however suggested that the cut offs
with best test performance to differentiate children with confirmed
TB and controls was similar to the cut offs to differentiate contacts
and controls, with similar AUC. Thus, similar to INFc and TST,
IP10 differentiated between infected and non-infected children but
is unable to differentiate between latent and active TB. Data from
children residing in a high burden areas is scarce and the
sensitivity of 81.8% obtained is lower than reported from Indian
adults [10] in Chennai (92.5%, 95%CI: 88.6%–96.4%), which
also reported a lower specificity (48%). Ruhwald et. al. [39]
selected a cut off of 673 pg/ml for Danish adolescents and adults
and Lighter et. al [12] selected a cut off of 732 pg/ml for USA
children. Applying Ruhwald et. al., cut off to Ethiopia would
increase the sensitivity to 86% and reduce the specificity to 48%,
which is similar to those reported by Kabeer et al in India,
suggesting that there is more agreement of test performance across
settings than suggested by these reports.
This study therefore describes INFc and IP10 expression in
children at different risk of infection and disease in a country with
a high incidence of TB. Children with probable TB had different
tests results patterns than children with confirmed TB as the former
had more TST but less INFc positive results, thus reflecting the
heterogeneity of this group and underscoring the importance of
using clear reporting group categories based on the certainty of
diagnosis to facilitate the interpretation of data.
Our findings therefore demonstrate that both INFc and IP10
identify children with latent and active TB. IP10 is less affected by
the presence of HIV co-infection than INFc and has the potential
to increase the sensitivity of the IGRAS when used in combination
with INFc. INFc, IP10 and TST however are unable to
differentiate between latent and active disease.
Longitudinal studies to describe the natural variation of these
markers over time and their ability to identify children with latent
infections at risk of disease progression or children at risk of poor
treatment response after initiation of anti-TB therapy are needed.
However, given the high cost of the IGRAS and the high
proportion of indeterminate results obtained, control programmes
should refrain from incorporating these tests until clear advantages
over the TST are demonstrated.
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